cancer - search results

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved

According to new research from Smith & Williamson, the accountancy, tax and investment management group, almost half (45%) of the tech scale-up businesses in the UK believe that the Government’s approach to Brexit and international trade will have no impact on them, while 30% think they stand to benefit.

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective

Many people don’t realise the harm that tobacco use does to the heart, a leading cardiologist has warned

Later today Environment Secretary Michael Gove will publish a Clean Air Strategy which aims to cut air pollution and save lives, backed up through new primary legislation

With the Government set to invest an additional £20 million into the research, diagnosis and development of treatments for brain tumours, Dr Ali Hansford elaborates on the need to talk more about how we are going to find the next blockbuster treatments for these devastating diseases

The European Commission today presents its contribution to the informal discussion that Heads of State and Government will hold in Sofia on 16 May 2018 on research and innovation and the steps needed to ensure Europe's global competitiveness

What will the future of medicine look like? A new virtual reality experience from the Association of the British Pharmaceutical Industry explores futuristic treatments and technologies like inhalable nanobots and 3D printed medicine patches

The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government

The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida

Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.

Michele Calabro’, European Health Management Association Policy and Communications Manager explains antimicrobial resistance (AMR), focussing on why Europe still needs to talk about a preventable crisis that could cause more deaths than cancer

Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today

Professor of Developmental Mechanics at the Department of Genetics, University of Cambridge, Alfonso Martinez Arias shares his expert view on Organoids, within the field of developmental biology.

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...

Ismail Čakmak of Sabanci University sheds light on the nutritional quality of minor cereals and their importance in the human diet.

Senior Scientist at the British Nutrition Foundation (BNF), Dr Lucy Chambers, offers food for thought, by detailing the complex relationship between diet and health

Europa Uomo – European Prostate Cancer Coalition Secretary, John Dowling shares his thoughts on the prostate gland, described as a most troublesome piece of tissue.

Donald A. Mahler from the Geisel School of Medicine at Dartmouth and Clinical Resource Center of the Alpha-1 Foundation and Valley Regional Hospital, on behalf of the CHEST Foundation, provides an expert view on shortness of breath (dyspnea)

Eigil Kjeldsen from Aarhus University Hospital gives an expert perspective on the drive towards precision and targeted medicine for acute leukaemia